Lok Sabha Question No. 40 (STARRED), answered on 2017-02-03
Subject: Expensive Coronary Stents
Ministry: HEALTH AND FAMILY WELFARE
Asked by: R. GOPALAKRISHNAN, SURESH KODIKUNNIL

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE

## LOK SABHA STARRED QUESTION NO. 40 TO BE ANSWERED ON THE 3 RD FEBRUARY , 2017 EXPENSIVE CORONARY S TENTS

## *40. SHRI R. GOPALAKRISHNAN: SHRI KODIKUNNIL SURESH:

Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:

- (a) whether the Government has taken note of rise in coronary heart dis and its expensive treatment;
- (b) if so, the measures taken by the Governm ent for the prevention, cure and treatment of such diseases and bring down the treatment costs;
- (c) whether a substantial amount is spent on the import of coronary stents
- (d) whether the Government has slashed the price of coronary stents and t he details thereof; and
- (e) the time by which such stents would be accessible to the patients at prices?

## ANSWER THE MINISTER OF STATE FOR HEALTH AND FAMILY WELFARE (SHRI FAGGAN SINGH KULASTE)

- (a) to ( e):  A statement is laid on the Table of the House

## STATEMENT REFERRED TO IN REPLY TO LOK SABHA STARRED QUESTION NO. 40* FOR 3 RD FEBRUARY, 2017

…..

(a) : A s informed by Indian Council of Medical Research (ICMR), current estimates from one - time cross sectional studies conducted in different regions of country indicate that the prevalence of coronary heart disease (CHD) is be 8- 10 percent in urban and 3 to 4 percent in rural India.

(b)& (c) : The Government of India is implementing National Programme for Prevention  and  Control  of  Cancer ,  Diabetes,  Cardiovascular  Diseases  and Stroke  (NPCDCS)  for  interventions  up  to  District  level  under  the  Nati Health Mission. It has focus on awareness generation for behaviour and -style changes, screening and early diagnosis of persons with high level of risk factors  and  their  treatment  and  referral  (if  required)  to  higher  faci appropriate  management  for  Non - communicable  Diseases.  Under  NPCDCS, diagnosis  and  treatment  facilities  for  major  NCDs  are  provided  thro different levels of he althcare by setting up of NCD Clinics and Cardiac Care Units ( CCUs )in District Hospitals and Community Health Centres (CHCs). The treatment  is  either  free  or  highly  subsidised  for  the  poor  and  needy government healthcare delivery system. Cardiology is focus area for setting up of  new  institutions  or  upgrade  of  existing  institutions  under  Pradhan Swasthya Suraksha Yojna.

It  is  a  fact thatIndian  medical  device  industry  is  primarily  import driven with imports contributing close to 75% of th e market.

(d) & (e) : Government notified inclusion of coronary stents in the National of Essential Medicines 2015 (NLEM, 2015) vide notification dated 19.7.20 and  subsequently  in  the  First  Schedule  of  Drugs  (Price  Control)  Order (DPCO  2013) vide  notification  dated  21.12.2016.    National  Pharmaceutic Pricing  Authority  (NPPA)  is  mandated  to  fix  the  ceiling  prices  of  Coro Stents  within  sixty  days  from  the  date  of  notification,  as  per  para  1 DPCO, 2013.

AMRIT (Affordable Medic ines a nd Reliable Implants for Treatment) stores are being set up by M/s HLL Lifecare Limited, a Government of Indi company, where essential lifesaving medicines and implants including ste are being provided at a substantial discount vis - à- vis the Maximum Retail Price.